Literature DB >> 16845567

Interferon beta in relapsing-remitting multiple sclerosis: an eight years experience in a specialist multiple sclerosis centre.

D S Goodin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16845567     DOI: 10.1007/s00415-006-0097-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Randomized trials or observational tribulations?

Authors:  S J Pocock; D R Elbourne
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study.

Authors:  Hillel Panitch; Aaron Miller; Donald Paty; Brian Weinshenker
Journal:  Neurology       Date:  2004-11-23       Impact factor: 9.910

3.  Interferon beta in relapsing-remitting multiple sclerosis. An eight years experience in a specialist multiple sclerosis centre.

Authors:  Jordi Río; Mar Tintoré; Carlos Nos; Nieves Téllez; Ingrid Galán; Xavier Montalban
Journal:  J Neurol       Date:  2005-03-18       Impact factor: 4.849

4.  Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial.

Authors:  H Panitch; D S Goodin; G Francis; P Chang; P K Coyle; P O'Connor; E Monaghan; D Li; B Weinshenker
Journal:  Neurology       Date:  2002-11-26       Impact factor: 9.910

5.  Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group.

Authors: 
Journal:  Neurology       Date:  1995-07       Impact factor: 9.910

6.  Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS.

Authors: 
Journal:  Lancet       Date:  1998-11-07       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.